Decoy Therapeutics (FP11) Q2 2025 Earnings Report
DE:FP11 Q2 2025 EPS Results
- Actual EPS
- -EUR 5.86
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 30.79
DE:FP11 Q2 2025 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/06/2025
- Time
- TBA
- Conference Call
- Wednesday, August 6, 2025
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:FP11 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2026 | 2025 (Q4) | ―- | -0.88 | ― | |
| Aug 06, 2025 | 2025 (Q2) | ―-5.86 | -30.79 | 80.98% (+24.94) | |
| May 08, 2025 | 2025 (Q1) | ―-0.89 | -0.35 | -150.49% (-0.53) | |
| Mar 24, 2025 | 2024 (Q4) | ―-13.18 | -22.84 | 42.28% (+9.66) | |
| Aug 07, 2024 | 2024 (Q2) | -46.38-2.05 | -9.9 | 79.28% (+7.85) | |
| May 09, 2024 | 2024 (Q1) | -5.80- | -1.93 | ― | |
| Mar 22, 2024 | 2023 (Q4) | -69.57-22.84 | -293.85 | 92.23% (+271.01) | |
| Nov 15, 2023 | 2023 (Q3) | -0.80-0.56 | -5.55 | 89.86% (+4.98) | |
| Aug 10, 2023 | 2023 (Q2) | -134.64-148.48 | -233.63 | 36.44% (+85.15) | |
| May 11, 2023 | 2023 (Q1) | -259.59-231.84 | -337.47 | 31.30% (+105.62) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
